BCI
PETX

Brinker Capital Investments’s Aratana Therapeutics, Inc. PETX Stock Holding History

Brinker Capital Investments’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,636
Closed -$100K – 532
2015
Q2 		$100K Hold
6,636
– – ﹤0.01% 300
2015
Q1 		$106K Hold
6,636
– – ﹤0.01% 287
2014
Q4 		$118K Hold
6,636
– – ﹤0.01% 280
2014
Q3 		$67K Hold
6,636
– – ﹤0.01% 270
2014
Q2 		$104K Buy
+6,636
New +$94K ﹤0.01% 276

Other funds holding PETX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brinker Capital Investments's PETX Position: Q3 2015 in Review

Brinker Capital Investments sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2015, closing a stake of 6,636 shares — an estimated $100K sold.

Brinker Capital Investments first reported a position in PETX in Q2 2014 and held it in 5 quarters. The position peaked at $118K in Q4 2014. 103 funds tracked by Wall St. Rank hold PETX as of Q3 2015.

  • Brinker Capital Investments reported no remaining Aratana Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • Brinker Capital Investments sold 6,636 Aratana Therapeutics, Inc. shares in Q3 2015, an estimated $100K.
  • Brinker Capital Investments first reported a position in Aratana Therapeutics, Inc. in Q2 2014 and held it in 5 quarters.
  • Brinker Capital Investments's Aratana Therapeutics, Inc. position peaked at $118K in Q4 2014.
  • 103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2015.

Based on Brinker Capital Investments's 13F filing for Q3 2015, filed 12 Nov 2015.